Obesity, Serum Prostate Specific Antigen and Prostate Size: Implications for Prostate Cancer Detection
Purpose
Obesity has been associated with lower serum testosterone, theoretically resulting in decreased PSA production. Obesity has also been associated with prostatic enlargement, making the detection of existent cancer more difficult. Together these findings would result in an apparent protective effect of obesity on prostate cancer risk due to technical detection issues unrelated to cancer biology. We examined the association between BMI, and PSA and prostate weight in a cohort of men undergoing RP.
Materials and Methods
We evaluated the association of BMI with prostate weight and PSA using linear regression, adjusting for patient age at RP, year of RP, race, and pathological stage and grade in 1,414 men treated with RP between 1988 and 2004 at the 5 equal access medical centers that comprise the Shared Equal Access Regional Cancer Hospital Database.
Results
On multivariate analysis increasing BMI was associated with increasing prostate weight but only in men younger than 63 years and not in men 63 years or older (p-trend <0.001 and 0.44, respectively). In men younger than 63 years mean multivariate adjusted prostate weight ± SE in those with a BMI of less than 25 vs 30 to 34.9 kg/m2 was 33.8 ± 1.4 vs 41.4 ± 1.6 gm. There was no significant association between BMI and preoperative PSA (p-trend = 0.70).
Conclusions
In a cohort of men undergoing RP obesity was associated with larger prostate size but only in younger men. There was no association between BMI and PSA. Assuming equal PSA, the degree of prostatic enlargement observed in younger obese men in this study would be expected to result in a modest decrease in the odds of detecting prostate cancer in a contemporary series of PSA screened men due to the decreased sensitivity of cancer detection related to larger prostate size. Obesity may appear protective for prostate cancer in younger men due to technical issues unrelated to cancer biology.
Key Words: prostate , prostatic neoplasms , prostatectomy , obesity , prostate-specific antigen
Abbreviations and Acronyms: BMI, body mass index , PSA, prostate specific antigen , RP, radical prostatectomy , SEARCH, Shared Equal Access Regional Cancer Hospital
To access this article, please choose from the options below
Study received Institutional Review Board approval at each institution.
Supported by the Department of Veterans Affairs, National Institutes of Health R01CA100938 (WJA), National Institutes of Health Specialized Programs of Research Excellence Grant P50 CA92131-01A1 (WJA), National Institutes of Health Specialized Programs of Research Excellence Grant Career Development Award P50CA58236 (EAP), the Georgia Cancer Coalition (MKT), Center for Prostate Disease Research (CPDR), a grant from the United States Army Medical Research and Materiel Command (CLA), Department of Defense, Prostate Cancer Research Program PC030666 (SJF) and DAMD 17-03-1-0273 (EAP), and an American Foundation for Urologic Disease/American Urological Association Education and Research Scholarship Award (SJF).
Views, opinions and endorsements are those of the authors.
PII: S0022-5347(05)00162-X
doi:10.1016/S0022-5347(05)00162-X
© 2006 American Urological Association. Published by Elsevier Inc. All rights reserved.

